- Category
- Small (2024-25)
- Udyam number
- UDYAM-DL-02-0032491

Caventis Pharma Private Limited
About Caventis Pharma Private Limited
Data last updated:
Caventis Pharma Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 22 August 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2012PTC240513. Its GSTIN is 09AAECC9443N1Z2 (Uttar Pradesh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Kushal Agrawal and Ketan Agrawal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 104 Ms Chamber Vikas Marg Laxmi Nagar, Delhi, India – 110092.
As per the financials filed for FY 2024, the company reported a revenue of ₹4.88 Cr, a decline of 11% compared to the previous year. For the same year it recorded a net profit of ₹7.11 Lakh (net margin 1.5%) and EBITDA of ₹33.05 Lakh (EBITDA margin 6.8%). Revenue has declined at a compounded annual rate (CAGR) of 14% over three years and 5% over five years.
The company is associated with 1 brand: Caventis. Court records list 23 cases involving the company, including 23 filed by the company; 7 cases are pending.
Caventis Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-02-0032491). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Caventis Pharma
Contact details
Caventis Pharma Private Limited's registered office is in Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered Address104 Ms Chamber Vikas Marg Laxmi Nagar, Delhi, India – 110092
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Caventis Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Caventis Pharma operates one associated brand: Caventis. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures and markets generic medicines including tablets, capsules, and syrups across India. | caventis.com |
Business activity
The main business activity of Caventis Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Caventis Pharma Private Limited, buy the company report.
Financials of Caventis Pharma Private Limited
FY 2025 filings availableCaventis Pharma Private Limited reported revenue of ₹4.88 Cr (down 11% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 5% over five years, including a 11% fall in the latest year. EBITDA rose 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹33.05 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7.11 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.8% | ||||
| Net Profit Margin | 1.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Caventis Pharma Private Limited, buy the company report.
Board of directors of Caventis Pharma Private Limited
Caventis Pharma has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kushal Agrawal Also directs: Rhizoid Healthcare Private Limited | Director | 19 Sep 2013 | 13 Years 2 Months | Current |
| Ketan Agrawal Also directs: Rhizoid Healthcare Private Limited | Director | 22 Oct 2018 | 8 Years 0 Months | Current |
Peer comparison
Caventis Pharma Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sanfegan Biotech Private Limited | ₹4.9 Cr (FY 2024) | 62.0% | Ernakulam, Kerala, India | |||
| Nexwin Pharma Private Limited | ₹4.89 Cr (FY 2024) | -4.0% | Panchkula, Haryana, India | |||
| Caventis Pharma Private Limitedthis company | ₹4.88 Cr (FY 2024) | ₹7.11 Lakh | 1.5% | -11.0% | Delhi, India | |
| Mag Pharma Private Limited | ₹4.87 Cr (FY 2025) | 6.0% | Delhi, India | |||
| Aarier Pharma Private Limited | ₹4.85 Cr (FY 2025) | 109.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Caventis Pharma Private Limited, buy the company report.
Auditor
Caventis Pharma Private Limited is audited by H U M S & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| H U M S & ASSOCIATES | FY 2020 | 022230N |
Shareholding
The shareholding of Caventis Pharma Private Limited is on record for 4 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Caventis Pharma Private Limited, buy the company report.
Legal cases
Caventis Pharma Private Limited has 23 court cases on record: 23 filed by Caventis Pharma. 7 cases are pending and 16 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 23 | 0 | 7 |
Cases on record (5 of 23)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Shahdara, Delhi | Cheque dishonour complaint | Filed by the company against an individual | Pending |
| District court, East, Delhi | Cheque dishonour complaint | Filed by the company against M/S United Medical Agencies | Pending |
| District court, East, Delhi | Cheque dishonour complaint | Filed by the company against M/S MSD Corporation and 1 other | Pending |
| District court, East, Delhi | Criminal case | Filed by the company against an individual | Pending |
| District court, East, Delhi | Criminal case | Filed by the company against M/S N.P. M. Distributors | Pending |
To see the full case history of Caventis Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Caventis Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Caventis Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAECC9443N1Z2 | Uttar Pradesh | Active | 20 Feb 2019 |
To see the full GST registrations and return filing status of Caventis Pharma Private Limited, buy the company report.
Recent activity
Caventis Pharma Private Limited has 7 board changes on record since 2013: 2 appointments and 5 cessations. The latest: Ketan Agrawal was appointed as Director on 22 Oct 2018.
Frequently asked questions
Caventis Pharma is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 22 August 2012 (14+ years old) and is registered under CIN U51909DL2012PTC240513.
Caventis Pharma has 2 current directors:
- Kushal Agrawal - Director
- Ketan Agrawal - Director
The latest financial statements of Caventis Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Caventis Pharma is 09AAECC9443N1Z2, registered in Uttar Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Caventis Pharma is U51909DL2012PTC240513. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Caventis Pharma has 23 court cases on record: 23 filed by the company. 7 are pending.
Caventis Pharma was incorporated on 22 August 2012, making it 14+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Caventis Pharma by revenue are Sanfegan Biotech Private Limited, Nexwin Pharma Private Limited, Mag Pharma Private Limited, Aarier Pharma Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Ketan Agrawal was appointed as Director on 22 Oct 2018. Tafseer Ahmed ceased to be Director on 29 May 2018. Musheer Ahmad ceased to be Director on 31 Mar 2017. Caventis Pharma has 7 board changes on record in total.
Yes, Caventis Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-DL-02-0032491).
The registered office of Caventis Pharma is at 104 Ms Chamber Vikas Marg Laxmi Nagar, Delhi, India – 110092.

